Exclusive breastfeeding during birth hospitalization was associated with a 22% reduction in the risk of childhood asthma. Infants whose first feeding was breast milk had a lower rate of asthma ...
One in 3 adolescents visiting a pediatric emergency department reported experiencing period poverty in the past year. Period poverty was not significantly associated with neighborhood opportunity, ...
Eric Simpson, MD, MCR, FAAD, lead author of a recently-published article highlighting roflumilast cream 0.15%, joined us for a Q+A interview. In this Q+A interview, Eric Simpson, MD, MCR, FAAD, ...
A study presented at the AAP 2024 National Conference & Exhibition finds Black infants are 40% more likely to die from congenital heart disease than White infants, highlighting persistent racial ...
In a recent study, infants of mothers with an influenza infection during pregnancy were significantly more likely to experience febrile seizures, but not epilepsy. The risk of childhood seizures is ...
In a recent global review, significant annual increases in the mean term birthweight were reported, indicating worldwide public health impacts. An increase in term birthweights over time has been ...
A recent study presented at the American Academy of Pediatrics 2024 National Conference & Exhibition, sheds light on the connection between skin conditions and sleep disturbances in infants and ...
A study presented at the American Academy of Pediatrics 2024 National Conference finds children with disabilities in foster care face lower permanency rates and higher mortality risks, calling for ...
In her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and ...
Our editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, previews some of the American Academy of Pediatrics National Conference & Exhibition, taking place right now in Orlando, Florida. Tina Tan, MD, ...
The needle-free option to treat type 1 allergic reactions, including anaphylaxis, was approved for adults and children who weigh 66 lbs or more on August 9, 2024. Epinephrine nasal spray (neffy; ARS ...
With this acceptance, the federal agency has assigned a PDUFA date of May 22, 2025 for roflumilast foam (Zoryve) 0.3%. Results from the phase 3 ARRECTOR trial, a phase 2b study, and long-term efficacy ...